Exact Sciences Announces Earnings Call Schedule
Exact Sciences Corp. (Nasdaq: EXAS), a prominent leader in cancer screening and diagnostic testing, is gearing up for the release of its fourth quarter financial results in 2024. The announcement reveals that these results will be shared after the close of U.S. financial markets on February 19, 2025. Following this release, the management team will engage in a webcast and conference call to share insights into company performance and ongoing projects.
Conference Call Details
The upcoming earnings call represents an important occasion for investors and stakeholders alike. It will take place at 5 p.m. ET on the same day as the earnings release. During this session, company leaders will discuss the financial outcomes of the last quarter and highlight key developments within the company.
How to Join the Webcast
For those interested in following the conversation, details for joining the webcast will be available. Participants can look forward to direct insights from the management regarding financial strategies and future outlook. The call is open to everyone, allowing all interested parties to hear about the latest advancements and performance updates directly from the company's experts.
Accessing the Webcast
The live session can be accessed via the company’s website, where a replay will also be available for further convenience. This feature ensures that those who cannot attend the live session can still stay informed about the discussions held during the call.
Contact Information for the Call
Investors attending the call should take note of the different contact numbers provided for both domestic and international callers. Those dialing in within the U.S. can reach the call by calling 888-330-2384. For international participants, the number is +1 240-789-2701. Each participant will need the access code 4437608 to join the conversation.
About Exact Sciences Corp.
Exact Sciences has made significant strides as a provider of vital cancer screening and diagnostic tests. With a focus on offering clarity and enabling timely healthcare interventions, the company has gained recognition for its valued products, including Cologuard® and Oncotype®. As part of a commitment to innovation, Exact Sciences is investing in a variety of developmental projects designed to enhance current offerings and launch new solutions for patient care at every stage of cancer diagnosis and treatment.
Frequently Asked Questions
What is the schedule for the Exact Sciences earnings call?
The earnings call is scheduled for February 19, 2025, at 5 p.m. ET, after the financial results are released.
How can I access the webcast for the earnings call?
The webcast will be accessible through the Exact Sciences website, and a replay will be available afterward.
What number should I call to join the earnings call?
You can join the call by calling 888-330-2384 within the U.S. and +1 240-789-2701 for international calls, using the access code 4437608.
What products is Exact Sciences known for?
Exact Sciences is primarily known for its cancer screening and diagnostic tests like Cologuard® and Oncotype®.
How is Exact Sciences preparing for the future?
The company is focused on innovation and expansion of its product pipeline to offer new solutions for patients before, during, and after a cancer diagnosis.